GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (NAS:CMND) » Definitions » Book Value per Share

Clearmind Medicine (Clearmind Medicine) Book Value per Share : $1.59 (As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine Book Value per Share?

Clearmind Medicine's book value per share for the quarter that ended in Jan. 2024 was $1.59.

During the past 12 months, Clearmind Medicine's average Book Value Per Share Growth Rate was -96.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -59.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Clearmind Medicine was 84.70% per year. The lowest was -59.40% per year. And the median was 12.65% per year.

Clearmind Medicine's current price is $1.23. Its book value per share for the quarter that ended in Jan. 2024 was $1.59. Hence, today's PB Ratio of Clearmind Medicine is 0.77.

During the past 7 years, the highest P/B Ratio of Clearmind Medicine was 146.10. The lowest was 0.00. And the median was 0.00.


Clearmind Medicine Book Value per Share Historical Data

The historical data trend for Clearmind Medicine's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine Book Value per Share Chart

Clearmind Medicine Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Book Value per Share
Get a 7-Day Free Trial 8.27 17.56 92.95 -18.48 1.17

Clearmind Medicine Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.51 10.49 8.99 1.17 1.59

Competitive Comparison of Clearmind Medicine's Book Value per Share

For the Biotechnology subindustry, Clearmind Medicine's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clearmind Medicine's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clearmind Medicine's PB Ratio distribution charts can be found below:

* The bar in red indicates where Clearmind Medicine's PB Ratio falls into.



Clearmind Medicine Book Value per Share Calculation

Clearmind Medicine's Book Value Per Share for the fiscal year that ended in Oct. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(0.71-0.00)/0.61
=1.17

Clearmind Medicine's Book Value Per Share for the quarter that ended in Jan. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(5.04-0.00)/3.17
=1.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Clearmind Medicine  (NAS:CMND) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Clearmind Medicine Book Value per Share Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Clearmind Medicine (Clearmind Medicine) Business Description

Traded in Other Exchanges
Address
101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Clearmind Medicine (Clearmind Medicine) Headlines

From GuruFocus